Literature DB >> 20561356

Inflammation in neurodegenerative diseases.

Sandra Amor1, Fabiola Puentes, David Baker, Paul van der Valk.   

Abstract

Neurodegeneration, the slow and progressive dysfunction and loss of neurons and axons in the central nervous system, is the primary pathological feature of acute and chronic neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease, neurotropic viral infections, stroke, paraneoplastic disorders, traumatic brain injury and multiple sclerosis. Despite different triggering events, a common feature is chronic immune activation, in particular of microglia, the resident macrophages of the central nervous system. Apart from the pathogenic role of immune responses, emerging evidence indicates that immune responses are also critical for neuroregeneration. Here, we review the impact of innate and adaptive immune responses on the central nervous system in autoimmune, viral and other neurodegenerative disorders, and discuss their contribution to either damage or repair. We also discuss potential therapies aimed at the immune responses within the central nervous system. A better understanding of the interaction between the immune and nervous systems will be crucial to either target pathogenic responses, or augment the beneficial effects of immune responses as a strategy to intervene in chronic neurodegenerative diseases.

Entities:  

Mesh:

Year:  2010        PMID: 20561356      PMCID: PMC2814458          DOI: 10.1111/j.1365-2567.2009.03225.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  114 in total

1.  C1q binding and complement activation by prions and amyloids.

Authors:  Robert B Sim; Uday Kishore; Christian L Villiers; Patrice N Marche; Daniel A Mitchell
Journal:  Immunobiology       Date:  2007-05-10       Impact factor: 3.144

2.  CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination.

Authors:  Charles L Howe; Daren Ure; Jaimie D Adelson; Reghann LaFrance-Corey; Aaron Johnson; Moses Rodriguez
Journal:  J Neuroimmunol       Date:  2007-05-09       Impact factor: 3.478

Review 3.  Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?

Authors:  Reinhard Hohlfeld
Journal:  J Neurol Sci       Date:  2007-04-24       Impact factor: 3.181

4.  Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses.

Authors:  Uwe Koedel; Ulrike Michaela Merbt; Caroline Schmidt; Barbara Angele; Bernadette Popp; Hermann Wagner; Hans-Walter Pfister; Carsten J Kirschning
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

5.  Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

Authors:  J Ludovic Croxford; Gareth Pryce; Samuel J Jackson; Catherine Ledent; Gavin Giovannoni; Roger G Pertwee; Takashi Yamamura; David Baker
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

Review 6.  Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.

Authors:  Marcus Kaul; Stuart A Lipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-06       Impact factor: 4.147

Review 7.  Alzheimer disease models and human neuropathology: similarities and differences.

Authors:  Charles Duyckaerts; Marie-Claude Potier; Benoît Delatour
Journal:  Acta Neuropathol       Date:  2007-11-16       Impact factor: 17.088

8.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Authors:  Barbara Serafini; Barbara Rosicarelli; Diego Franciotta; Roberta Magliozzi; Richard Reynolds; Paola Cinque; Laura Andreoni; Pankaj Trivedi; Marco Salvetti; Alberto Faggioni; Francesca Aloisi
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

9.  Neurofascin as a novel target for autoantibody-mediated axonal injury.

Authors:  Emily K Mathey; Tobias Derfuss; Maria K Storch; Kieran R Williams; Kimberly Hales; David R Woolley; Abdulmonem Al-Hayani; Stephen N Davies; Matthew N Rasband; Tomas Olsson; Anja Moldenhauer; Sviataslau Velhin; Reinhard Hohlfeld; Edgar Meinl; Christopher Linington
Journal:  J Exp Med       Date:  2007-09-10       Impact factor: 14.307

10.  Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.

Authors:  Ikuo Tsunoda; Tomoko Tanaka; Yukio Saijoh; Robert S Fujinami
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

View more
  450 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  The executioners sing a new song: killer caspases activate microglia.

Authors:  J L Venero; M A Burguillos; P Brundin; B Joseph
Journal:  Cell Death Differ       Date:  2011-08-12       Impact factor: 15.828

Review 3.  In Vitro Models for Neurogenesis.

Authors:  Hassan Azari; Brent A Reynolds
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

Review 4.  SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?

Authors:  Juliana B Hoppe; Christianne G Salbego; Helena Cimarosti
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 5.  Supportive or detrimental roles of P2Y receptors in brain pathology?--The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studies.

Authors:  Daniel Förster; Georg Reiser
Journal:  Purinergic Signal       Date:  2015-09-25       Impact factor: 3.765

Review 6.  Inflammation in neurodegenerative diseases--an update.

Authors:  Sandra Amor; Laura A N Peferoen; Daphne Y S Vogel; Marjolein Breur; Paul van der Valk; David Baker; Johannes M van Noort
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 7.  Inflammation-on-a-Chip: Probing the Immune System Ex Vivo.

Authors:  Daniel Irimia; Xiao Wang
Journal:  Trends Biotechnol       Date:  2018-05-01       Impact factor: 19.536

8.  Systemic LPS induces spinal inflammatory gene expression and impairs phrenic long-term facilitation following acute intermittent hypoxia.

Authors:  A G Huxtable; S M C Smith; S Vinit; J J Watters; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2013-01-17

9.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

Review 10.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.